For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Immune Modulator

Thymalin

Also known as: thymalinum

Thymalin is a heterogeneous polypeptide extract from calf thymus (a mixture, not a single defined peptide) developed in the 1970s by V. Kh. Khavinson and V. G. Morozov at the Military Medical Academy / St. Petersburg Institute of Bioregulation and Gerontology. Registered as a pharmaceutical in the USSR/Russia for immunocorrection. Distinct from Thymulin (Bach's zinc-dependent nonapeptide pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, originally called FTS) and from Thymosin alpha-1 (a 28-amino-acid synthetic peptide). Not FDA-approved in the US; research-use only.

Real-time market data

Pricing for Thymalin

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Average price

$4.68/mg

range $1.52–$6.50/mg

Sellers

27

from $0.00

45-day trend

+0.7%

vs 45-day avg $/mg

24 of 27 sellers have a current price· 14 stale listings hidden (not seen in 7 days)

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Independent evidence

COAs for Thymalin

21 third-party tests across 5 vendors. Each card links to the full report.

All 21 COAs for Thymalin →
Measured purity 99.2%–99.9% across 14 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.21 %
May 2026
Freedom Diagnostics Moderate

For

Thymalin

by Profound Aminos· batch Dark Blue Cap

✓ Vendor-published
99.20 %
Feb 2026
Analytical Formulations, Inc.

For

Thymalin

by Ion Peptide· batch THY10-02232026

COA on file
Aggregated · 3rd-party listing
99.50 %
Jan 2026
Freedom Diagnostics Moderate

For

Thymalin

by Kimera Chems· batch KC-TYL-BLU1

Aggregated · 3rd-party listing
99.76 %
Dec 2025
Janoshik Analytical Limited · HPLC

For

Thymalin

by Verified Peptides· batch 01-26-0710G

Aggregated · 3rd-party listing
99.80 %
Dec 2025
Vanguard Laboratory Strong

For

Thymalin

by Peptidology· batch 1668

Aggregated · 3rd-party listing
99.15 %
Sep 2025
Vanguard Laboratory Strong

For

Thymalin

by Peptidology· batch 1664

Aggregated · 3rd-party listing
99.60 %
Sep 2025
Janoshik Analytical Limited · HPLC

For

Thymalin

by Verified Peptides· batch 09-25-0510E

Aggregated · 3rd-party listing
99.59 %
Jun 2025
Janoshik Analytical Limited · HPLC

For

Thymalin

by Verified Peptides· batch 06-25-0410D

✓ Vendor-published
99.59 %
Jun 2025
Janoshik Analytical Limited

For

Thymalin

by Verified Peptides· batch 06-25-0410D

COA on file
Aggregated · 3rd-party listing
99.86 %
Feb 2025
Janoshik Analytical Limited · HPLC

For

Thymalin

by Verified Peptides· batch 12-24-0310C

✓ Vendor-published
99.86 %
Feb 2025
Janoshik Analytical Limited

For

Thymalin

by Verified Peptides· batch 12-24-0310C

COA on file
Aggregated · 3rd-party listing
99.91 %
Aug 2024
Janoshik Analytical Limited · HPLC

For

Thymalin

by Verified Peptides· batch 07-24-0210B

Aggregated · 3rd-party listing
99.91 %
Aug 2024
Janoshik Analytical Limited · HPLC

For

Thymalin

by Verified Peptides· batch 07-24-0210B

✓ Vendor-published
99.91 %
Aug 2024
Janoshik Analytical Limited

For

Thymalin (Thymulin)

by Verified Peptides· batch 07-24-0210B

COA on file
Aggregated · 3rd-party listing
99.73 %
Freedom Diagnostics Moderate

For

Thymalin

by Simple Peptide· batch TMA20-02 182026-J

Aggregated · 3rd-party listing
99.31 %
Kovera Labs

For

Thymalin

by Real Peptides· batch RP0522026

Aggregated · 3rd-party listing
99.20 %
Analytical Formulations, Inc.

For

Thymalin

by Ion Peptide· batch THY10-02232026

Aggregated · 3rd-party listing
Dec 2025

Purity not on file

Janoshik Analytical Limited

For

Thymalin

by Verified Peptides· batch 01-26-0710G

Aggregated · 3rd-party listing
Sep 2025

Purity not on file

Janoshik Analytical Limited

For

Thymalin

by Verified Peptides· batch 09-25-0510E

Aggregated · 3rd-party listing
Feb 2025

Purity not on file

Janoshik Analytical Limited

For

Thymalin

by Verified Peptides· batch 12-24-0310C

Aggregated · 3rd-party listing
Aug 2024

Purity not on file

Janoshik Analytical Limited

For

Thymalin

by Verified Peptides· batch 07-24-0210B

Research depth

12 citations indexed for Thymalin

All research on Thymalin →

review · 2026

Targeting Leukopoiesis: Pharmacological and Biotechnological Strategies for the Treatment of Leukopenia

Leukopenia remains a major clinical challenge associated with infectious diseases, oncological therapies, autoimmune disorders, and metabolic and iatrogenic conditions.

review · 2025

Rerouting therapeutic peptides and unlocking their potential against SARS-CoV2

The COVID-19 pandemic highlighted the potential of peptide-based therapies as an alternative to traditional pharmaceutical treatments for SARS-CoV-2 and its variants. Our review explores the role of therapeutic peptides in modulating immune responses, inhibiting viral entry, and disrupting replication.

Study · 2024

Reparative osteogenesis in mandible in cases of filling a bone defect with hydroxyapatite-containing osteotropic material and injecting the surrounding soft tissues with thymalin: experimental and morphological study

Objective Aim of the study was to identify the morphological features of reparative osteogenesis in the lower jaw bone of rats in cases of filling a bone defect with hydroxyapatite-containing osteotropic material (bone graft "Biomin GT") and injecting the surrounding soft tissues with thymalin.

animal · 2024

Expression features of T-lymphocytes, B-lymphocytes and macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding soft tissues

Objective Aim: The purpose of the study was to determine the features of the expression of T-lymphocytes, B-lymphocytes, macrophages in the post-traumatic regenerate of the mandible rats under conditions of filling a bone defect with hydroxyapatite-containing osteotropic material and thymalin injecting the surrounding…

Study · 2023

The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19

Thymalin is an immunomodulatory drug containing a polypeptide extract of thymus that has demonstrated efficacy in the therapy of acute respiratory distress syndrome and chronic obstructive pulmonary disease, as well as in complex therapy related to severe COVID-19 in middle-aged and elderly patients..

Study · 2022

[Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin.]

The aim of the work was a comparative study of Tocilizumab and Thymalin effects on the morphological composition and indicators of the blood clotting system in COVID-19 of middle aged and elderly patients.